检索范围:
排序: 展示方式:
《医学前沿(英文)》 2023年 第17卷 第4期 页码 781-795 doi: 10.1007/s11684-023-0986-x
关键词: dry eye disease glycolytic reprogramming pyroptosis inflammation 2-DG
Fengxia YIN,Hui LIU,Shorgan BOU,Guangpeng LI
《农业科学与工程前沿(英文)》 2014年 第1卷 第2期 页码 104-113 doi: 10.15302/J-FASE-2014003
关键词: nuclear reprogramming somatic cell transcription factors transcriptomics
Genome reprogramming for synthetic biology
Kylie Standage-Beier,Xiao Wang
《化学科学与工程前沿(英文)》 2017年 第11卷 第1期 页码 37-45 doi: 10.1007/s11705-017-1618-2
关键词: CRISPR genome engineering synthetic biology rational design
《医学前沿(英文)》 2021年 第15卷 第5期 页码 679-692 doi: 10.1007/s11684-021-0866-1
关键词: metabolic reprogramming potential of electron transfer cell proliferation aerobic glycolysis cancer metabolism
Reprogramming of the pig primordial germ cells into pluripotent stem cells: a brief review
Qijing LEI, Qin PAN, Shuai YU, Na LI, Shulin CHEN, Kuldip SIDHU, Jinlian HUA
《农业科学与工程前沿(英文)》 2019年 第6卷 第1期 页码 28-32 doi: 10.15302/J-FASE-2018222
Primordial germ cells (PGCs) are regarded as unipotent cells that can produce only either spermatogonia or oocytes. However, PGCs can be converted into the pluripotent state by first dedifferentiation to embryonic germ cells and then by reprogramming to induce them to become pluripotent stem cells (iPSCs). These two stages can be completely implemented with mouse cells. However, authentic porcine iPSCs have not been established. Here, we discuss recent advances in the stem cell field for obtaining iPSCs from PGCs. This knowledge will provide some clues which will contribute to the regulation of reprogramming to pluripotency in farm species.
关键词: pig pluripotent stem cells primordial germ cells reprogramming
Immunometabolism: a new dimension in immunotherapy resistance
《医学前沿(英文)》 2023年 第17卷 第4期 页码 585-616 doi: 10.1007/s11684-023-1012-z
关键词: immune cell immunometabolism metabolic reprogramming immunotherapy resistance tumor microenvironment immune checkpoint inhibitor
韩为东,赵亚力,付小兵
《中国工程科学》 2009年 第11卷 第5期 页码 81-87
通过特定的基因组合与转染可以将已分化的体细胞诱导重编程为多潜能干细胞(iPS),是近年来干细胞研究领域最令人瞩目的一项新的干细胞制造技术。与胚胎干细胞(ES)不同,iPS细胞的制造不需要毁损胚胎,因而不会涉及更多的伦理学问题。iPS的出现不仅为体细胞重编程去分化机制的研究注入了新的活力,而且为疾病发生发展相关机制研究与特异的细胞治疗,特别是再生医学带来新的曙光。目前,iPS的研究尚处于初级阶段,文章就iPS的研究现状与应用前景进行综述和展望。
《医学前沿(英文)》 页码 805-822 doi: 10.1007/s11684-023-1025-7
关键词: CTLA-4 PD-1 PD-L1 immune checkpoint blockade (ICB) metabolic reprogramming combined tumor therapeutic strategies
Progress, problems and prospects of porcine pluripotent stem cells
Hanning WANG,Yangli PEI,Ning LI,Jianyong HAN
《农业科学与工程前沿(英文)》 2014年 第1卷 第1期 页码 6-15 doi: 10.15302/J-FASE-2014009
关键词: induced pluripotent stem cells embryonic stem cells pig reprogramming
标题 作者 时间 类型 操作
Hyperosmolarity promotes macrophage pyroptosis by driving the glycolytic reprogramming of corneal epithelial
期刊论文
Oocyte-associated transcription factors in reprogramming after somatic cell nuclear transfer: a review
Fengxia YIN,Hui LIU,Shorgan BOU,Guangpeng LI
期刊论文
transfer and its application in dictating routes of biochemical processes associated with metabolic reprogramming
期刊论文
Reprogramming of the pig primordial germ cells into pluripotent stem cells: a brief review
Qijing LEI, Qin PAN, Shuai YU, Na LI, Shulin CHEN, Kuldip SIDHU, Jinlian HUA
期刊论文
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
期刊论文